#liver cancer

Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.

Current screening guidelines may shortchange Black individuals.

The disease has similar prevalence across high-income and low- and middle-income nations.

Mice that performed modest exercise were less likely to show signs of inflammation, cell aging and liver cancer.

Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.

Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.

Compared to other racial and ethnic groups, Blacks are also less likely to be diagnosed early.

The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.

A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Areas with lower population density have not seen the same slowdown as urban areas.

Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.

New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.

Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.

October is Liver Cancer Awareness Month.

Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.

NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.